CRISPR-engineered bacterial payload acts as antibiotic

A New York University School of Medicine team has proposed a new type of antibiotic that turns Staphylococcus aureus against itself by genetically engineering the bacteria’s pathogenic payloads to deliver antibacterial cargos.

The system could be an alternative to traditional antibiotics and bacteriophage-based therapies, against which bacteria are becoming increasingly resistant...